Get the Stockscreener App
10.28
0.69%
0.07
After Hours:
10.26
-0.02
-0.19%
Tempest Therapeutics Inc stock is traded at $10.28, with a volume of 38,874.
It is up +0.69% in the last 24 hours and up +3.63% over the past month.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
See More
Previous Close:
$10.21
Open:
$10.22
24h Volume:
38,874
Relative Volume:
0.53
Market Cap:
$45.64M
Revenue:
-
Net Income/Loss:
$-43.10M
P/E Ratio:
-1.0631
EPS:
-9.67
Net Cash Flow:
$-36.82M
1W Performance:
+15.51%
1M Performance:
+3.63%
6M Performance:
+7.15%
1Y Performance:
-43.52%
1-Day Range:
$10.09
$10.33
1-Week Range:
$8.87
$10.41
52-Week Range:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Name
Tempest Therapeutics Inc
Sector
Industry
Phone
415-798-8589
Address
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.28 | 45.33M | 0 | -43.10M | -36.82M | -9.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-08-24 | Initiated | Jefferies | Buy |
Tempest Therapeutics Inc Stock (TPST) Latest News
How Tempest Therapeutics Inc. stock benefits from global expansionEarnings Growth Report & Expert Verified Movement Alerts - newser.com
What moving averages say about Tempest Therapeutics Inc.Trade Analysis Summary & Verified Stock Trade Ideas - newser.com
Real time social sentiment graph for Tempest Therapeutics Inc.July 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Is Tempest Therapeutics Inc. still worth holding after the dipPortfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Applying chart zones and confluence areas to Tempest Therapeutics Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Can Tempest Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Should you wait for a breakout in Tempest Therapeutics Inc.July 2025 Update & AI Driven Stock Reports - newser.com
Published on: 2025-09-29 11:05:27 - earlytimes.in
Chart based analysis of Tempest Therapeutics Inc. trendsStop Loss & Stock Portfolio Risk Control - newser.com
Can a trend reversal in Tempest Therapeutics Inc. lead to recoveryGold Moves & Real-Time Chart Breakout Alerts - newser.com
Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight - GlobeNewswire Inc.
Will Tempest Therapeutics Inc. rebound enough to break evenJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Tempest Therapeutics Inc. stock prediction for this week2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Regression analysis insights on Tempest Therapeutics Inc. performanceMarket Risk Summary & Daily Entry Point Trade Alerts - newser.com
Identifying reversal signals in Tempest Therapeutics Inc.Quarterly Profit Report & Real-Time Stock Movement Alerts - newser.com
Risk adjusted return profile for Tempest Therapeutics Inc. analyzed2025 Historical Comparison & Growth Focused Investment Plans - newser.com
How to escape a deep drawdown in Tempest Therapeutics Inc.Weekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Is Tempest Therapeutics Inc. stock ready for a breakoutPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
Tempest Therapeutics Inc Stock (TPST) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):